HCM
HUTCHMED DRC
NASDAQ: HCM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.32
-3.48% today
Updated 2026-10-28
Market cap
$2.44B
P/E ratio
140.50
P/S ratio
4.45x
EPS (TTM)
$0.10
Dividend yield
—
52W range
$10 – $16
Volume
0.1M
HUTCHMED DRC (HCM) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.32
12-Month target
$13.80
2030 Target
—
Intrinsic (DCF)
$25.53
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.8B | $0.6B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 3.26%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.